Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Operating Income 2023–2025
Entrada Therapeutics Inc. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Entrada Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -42.3 M, a 94.14% increase year-over-year.
- Entrada Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -158.0 M, a 336.20% decrease year-over-year.
- Entrada Therapeutics Inc. annual operating income for 2025 was -157.9 M, a 435.87% decrease from 2024.
- Entrada Therapeutics Inc. annual operating income for 2024 was 47.0 M, a 1586.75% decrease from 2023.
- Entrada Therapeutics Inc. annual operating income for 2023 was -3.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Entrada Therapeutics Inc. Operating Income — FAQ
Entrada Therapeutics Inc. (TRDA) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Entrada Therapeutics Inc.'s operating income?
Entrada Therapeutics Inc. (TRDA) reported operating income of -$158M for fiscal 2025.
Where can I see TRDA's operating income history?
The chart and table above show Entrada Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.